[Federal Register Volume 68, Number 169 (Tuesday, September 2, 2003)]
[Notices]
[Page 52225]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-22330]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to section 1301.33(a) of title 21 of the Code of Federal 
Regulations (CFR), this is notice that on February 9, 2003, Lin-Zhi 
International, Inc., 687 North Pastoria Avenue, Sunnyvale, California 
94085-2917, made application to the Drug Enforcement Administration 
(DEA) for registration as a bulk manufacturer of the basic classes of 
controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)...............  I
3,4-Methylenedioxymethamphetamine (7405)...  I
Amphetamine (1100).........................  II
Methamphetamine (1105).....................  II
Secrobarbital (2315).......................  II
Phencyclidine (7471).......................  II
Cocaine (9041).............................  II
Methadone (9250)...........................  II
Dextropropoxyphene (9273)..................  II
Morphine (9300)............................  II
------------------------------------------------------------------------

    The firm plans to manufacture small quantities of controlled 
substances to make drug testing reagents and controls.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quituplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: Federal Register Representative, 
Officer of Chief Counsel (CCD) and must be filed no later than November 
3, 2003.

    Dated: August 19, 2003.
Laura M. Nagel,
Assistant Administrator, Office of Diversion Control, Drug Enforcement 
Administration.
[FR Doc. 03-22330 Filed 8-29-03; 8:45 am]
BILLING CODE 4410-09-M